Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro | Zendy

Jelena Stojnić | Zendy; Aleksandar Ljubić | Zendy; Katarina Jeremić | Zendy; Nebojša Radunović | Zendy; Ivan Tulic | Zendy; V. Boskovic | Zendy; Jelena Dukanac | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro

Author(s) -

Jelena Stojnić,

Aleksandar Ljubić,

Katarina Jeremić,

Nebojša Radunović,

Ivan Tulic,

V. Boskovic,

Jelena Dukanac

Publication year - 2006

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0606558s

Subject(s) - medicine , misoprostol , abortion , obstetrics , vomiting , vaginal bleeding , population , incidence (geometry) , curettage , adverse effect , gynecology , pregnancy , anesthesia , surgery , genetics , physics , environmental health , optics , biology

Medicamentous abortion was first introduced in Serbia and Montenegro in September 2001. The aim of this study was to assess the efficiency, side effects, and acceptability of medicamentous abortion using mifeprostone orally (600 mg), and 48 hours later, misoprostol both orally and vaginally in different regiments in our population (400 mcg, 600 mcg, 800 mcg).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research